-
HLB Science Completes Phase 1 Trial of New Antibiotic for Sepsis and SuperbugsBig Tech 2025. 7. 3. 01:48반응형
HLB Science completed dosing in the Phase 1 clinical trials of its investigational antibiotic 'DD-S052P' for sepsis and superbug infections in both France and the United States. The company expects to receive the final Clinical Study Report (CSR) by the end of August.
Read more: https://www.ittimes.com/news/articleView.html?idxno=79211HLB Science Completes Phase 1 Trial of New Antibiotic for Sepsis and Superbugs - IT타임스
HLB Science announced on July 2 that it has completed dosing in the Phase 1 clinical trials of its investigational antibiotic 'DD-S052P' for sepsis and superbug infections in both France and the Un...
www.ittimes.com
반응형'Big Tech' 카테고리의 다른 글
에버랜드, 핑크퐁 '아기상어∙베베핀' 테마존 4일 오픈 (0) 2025.07.03 쿠팡, 여름 인기 원피스 최대 70% 할인 '원피스페어' 개최 (0) 2025.07.03 관광공사, APEC 앞두고 외국인 간편결제 QR 인프라 확대 (0) 2025.07.02 '컴프야2025'∙'컴프야V25', 해태제과 '홈런볼'과 여름 제휴 이벤트 (0) 2025.07.02 HLB사이언스, 패혈증 치료제 'DD-S052P' 글로벌 임상1상 투약 완료 (0) 2025.07.02